Evidence map›Paper›PMID 20088699›Full record

ArticleTissue engineering. Part A2010

Scaffold-free in vitro arterial mimetics: the importance of smooth muscle-endothelium contact.

Somali Chaterji, Kinam Park, Alyssa Panitch

Abstract read
In one paragraph

Article in Tissue engineering. Part A, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Key parameters for designing robust 2D and 3D spheroid models forBioengineering & translational medicine · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Recent Progress inFrontiers in cardiovascular medicine · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Trends in tissue engineering for blood vessels.Journal of biomedicine & biotechnology · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Somali ChaterjiWeldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana 47907, USA.
Kinam Park
Alyssa Panitch

Funding

Layer-by-layer assembly for making drug-eluting stentsR01HL078715 · NHLBI · PURDUE UNIVERSITY WEST LAFAYETTE · PI PARK, KINAM · 2005 to 2007
$1.1M
Layer by layer assembly for making drug-eluting stentsR56HL078715 · NHLBI · PURDUE UNIVERSITY · PI PARK, KINAM · 2009 to 2009
$352k
NHLBI NIH HHS HL078715
6 · The paper itself

Abstract

We have developed an in vitro endothelial cell (EC)-smooth muscle cell (SMC) coculture platform that can mimic either the healthy or diseased state of blood vessels. Transforming growth factor-beta1 (TGF-beta1) and heparin were introduced to the SMC cultures to upregulate the SMC differentiation markers, alpha-smooth muscle actin (alpha-SMA) and calponin (homotypic model). Interestingly, seeding of near-confluent concentrations of ECs on the SMCs (heterotypic model) induced higher levels of alpha-SMA and calponin expression in the SMC cultures than did the addition of heparin and TGF-beta1 alone. The expression levels increased further on pretreating the SMCs with TGF-beta1 and heparin before adding a near-confluent monolayer of ECs. In contrast, seeding of sparse concentrations of ECs forced the SMCs into a more hyperplastic state as determined by alpha-SMA and calponin expression. This study highlights the importance of both soluble factors and EC seeding densities when considering culture conditions; in vivo SMCs are in close proximity with and interact with a monolayer of ECs. Our study suggests that this architecture is important for healthy vascular tissue function. In addition, it shows that disruption of this architecture can be used to mimic diseased states. As the EC-SMC coculture model can mimic either a diseased or a healthy blood vessel it may be useful as a test bed for evaluating cardiovascular therapeutics.

Indexed as

ActinsArteriesCalcium-Binding ProteinsCalponinsCells, CulturedCoculture TechniquesEndothelial CellsEndothelium, VascularHeparinHumansMicrofilament ProteinsMuscle, Smooth, VascularMyocytes, Smooth MuscleTissue EngineeringTransforming Growth Factor beta1ACTA2 protein, humanActinsCalcium-Binding ProteinsCalponinsHeparinMicrofilament ProteinsTransforming Growth Factor beta1

Identifiers

PMID20088699
PMCPMC2949266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.